Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice

被引:1
|
作者
Rudolph, D
Yeh, WC
Wakeham, A
Rudolph, B
Nallainathan, D
Potter, J
Elia, AJ
Mak, TW [1 ]
机构
[1] Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[3] Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada
[4] Imperial Canc Res Fund, London WC2A 3PX, England
关键词
NEMO/IKK gamma; IKK; NF-kappa B; liver apoptosis;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Phosphorylation of I kappa B, an inhibitor of NF-kappa B, is an important step in the activation of the transcription factor NF-kappa B. Phosphorylation is mediated by the I kappa B kinase (IKK) complex, known to contain two catalytic subunits: IKK alpha and IKK beta. A novel, noncatalytic component of this kinase complex called NEMO (NF-kappa B essential modulator)/IKK gamma was identified recently. We have generated NEMO/IKK gamma-deficient mice by gene targeting. Mutant embryos die at E12.5-E13.0 from severe liver damage due to apoptosis. NEMO/ IKK gamma-deficient primary murine embryonic fibroblasts (MEFs) lack detectable NF-kappa B DNA-binding activity in response to TNF alpha, IL-1, LPS, and Poly(IC) and do not show stimulus-dependent I kappa B kinase activity, which correlates with a lack of phosphorylation and degradation of I kappa B alpha. Consistent with these data, mutant MEFs show increased sensitivity to TNF alpha-induced apoptosis. Our data provide in vivo evidence that NEMO/IKK gamma is the first essential, noncatalytic component of the IKK complex.
引用
收藏
页码:854 / 862
页数:9
相关论文
共 50 条
  • [21] Involvement of linear polyubiquitylation of NEMO in NF-κB activation
    Tokunaga, Fuminori
    Sakata, Shin-ichi
    Saeki, Yasushi
    Satomi, Yoshinori
    Kirisako, Takayoshi
    Kamei, Kiyoko
    Nakagawa, Tomoko
    Kato, Michiko
    Murata, Shigeo
    Yamaoka, Shoji
    Yamamoto, Masahiro
    Akira, Shizuo
    Takao, Toshifumi
    Tanaka, Keiji
    Iwai, Kazuhiro
    NATURE CELL BIOLOGY, 2009, 11 (02) : 123 - U40
  • [22] Finding NEMO:: genetic disorders of NF-κB activation
    Orange, JS
    Geha, RS
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07): : 983 - 985
  • [23] NF-κB activation:: nondegradative ubiquitination implicates NEMO
    Israel, Alain
    TRENDS IN IMMUNOLOGY, 2006, 27 (09) : 395 - 397
  • [24] Sequential modification of NEMO/IKKγ by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress
    Huang, TT
    Wuerzbrger-Davis, SM
    Wu, ZH
    Miyamoto, S
    CELL, 2003, 115 (05) : 565 - 576
  • [25] NEMO-IKKβ Are Essential for IRF3 and NF-κB Activation in the cGAS-STING Pathway
    Fang, Run
    Wang, Chenguang
    Jiang, Qifei
    Lv, Mengze
    Gao, Pengfei
    Yu, Xiaoyu
    Mu, Ping
    Zhang, Rui
    Bi, Sheng
    Feng, Ji-Ming
    Jiang, Zhengfan
    JOURNAL OF IMMUNOLOGY, 2017, 199 (09): : 3222 - 3233
  • [26] IKKα takes control of canonical NF-κB activation
    Christiane Pelzer
    Margot Thome
    Nature Immunology, 2011, 12 : 815 - 816
  • [27] IKKα takes control of canonical NF-κB activation
    Pelzer, Christiane
    Thome, Margot
    NATURE IMMUNOLOGY, 2011, 12 (09) : 815 - 816
  • [28] The IKK Complex, a Central Regulator of NF-κB Activation
    Israel, Alain
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (03): : a000158
  • [29] Protective role of IKKγ/NEMO driven NF-κB response during ischemia/reperfusion induced liver damage
    Beraza, Naiara
    Luedde, Tom
    Assmus, Ulrike
    Roskams, Tania
    Malato, Yann
    Borght, Sara Vander
    Pasparakis, Manolis
    Trautwein, Christian
    HEPATOLOGY, 2006, 44 (04) : 218A - 218A
  • [30] NEMO/IKKγ-deficient mice model incontinentia pigmenti
    Schmidt-Supprian, M
    Bloch, W
    Courtois, G
    Addicks, K
    Israël, A
    Rajewsky, K
    Pasparakis, M
    MOLECULAR CELL, 2000, 5 (06) : 981 - 992